CAMP4 Therapeutics Corp. (CAMP)
4.15
-0.02
(-0.48%)
USD |
NASDAQ |
Sep 22, 16:00
4.15
0.00 (0.00%)
After-Hours: 20:00
CAMP4 Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 7.461 |
| June 26, 2026 | 7.057 |
| June 25, 2026 | 6.587 |
| June 24, 2026 | 6.772 |
| June 23, 2026 | 7.326 |
| June 22, 2026 | 7.057 |
| June 18, 2026 | 6.940 |
| June 17, 2026 | 6.957 |
| June 16, 2026 | 6.940 |
| June 15, 2026 | 6.654 |
| June 12, 2026 | 7.041 |
| June 11, 2026 | 7.091 |
| June 10, 2026 | 7.293 |
| June 09, 2026 | 6.738 |
| June 08, 2026 | 6.873 |
| June 05, 2026 | 6.906 |
| June 04, 2026 | 7.225 |
| June 03, 2026 | 7.007 |
| June 02, 2026 | 6.688 |
| June 01, 2026 | 6.788 |
| May 29, 2026 | 7.377 |
| May 28, 2026 | 7.545 |
| May 27, 2026 | 7.074 |
| May 26, 2026 | 6.889 |
| May 22, 2026 | 7.578 |
| Date | Value |
|---|---|
| May 21, 2026 | 7.394 |
| May 20, 2026 | 7.562 |
| May 19, 2026 | 6.973 |
| May 18, 2026 | 7.662 |
| May 15, 2026 | 7.242 |
| May 14, 2026 | 7.360 |
| May 13, 2026 | 7.562 |
| May 12, 2026 | 7.562 |
| May 11, 2026 | 7.394 |
| May 08, 2026 | 7.494 |
| May 07, 2026 | 7.293 |
| May 06, 2026 | 6.822 |
| May 05, 2026 | 6.688 |
| May 04, 2026 | 6.486 |
| May 01, 2026 | 6.805 |
| April 30, 2026 | 7.007 |
| April 29, 2026 | 6.738 |
| April 28, 2026 | 7.175 |
| April 27, 2026 | 7.461 |
| April 24, 2026 | 7.461 |
| April 23, 2026 | 7.461 |
| April 22, 2026 | 7.662 |
| April 21, 2026 | 7.763 |
| April 20, 2026 | 7.578 |
| April 17, 2026 | 7.545 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| MannKind Corp. | -- |
| Ocugen, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 3.479 |
| Alnylam Pharmaceuticals, Inc. | 24.85 |
| Anika Therapeutics, Inc. | 2.036 |
Price to Book Value Related Metrics
| PS Ratio | 47.99 |
| Price | 4.15 |
| Earnings Yield | -53.62% |
| Market Cap | 215.50M |